ProAssurance Gestione
Criteri Gestione verificati 4/4
ProAssurance Il CEO è Ned Rand, nominato in Dec2018, e ha un mandato di 7.5 anni. la retribuzione annua totale è $ 5.30M, composta da 19.6% di stipendio e 80.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.57% delle azioni della società, per un valore di $ 7.26M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 10.7 anni e 7.1 anni.
Informazioni chiave
Ned Rand
Amministratore delegato
US$5.3m
Compenso totale
| Percentuale dello stipendio del CEO | 19.64% |
| Mandato del CEO | 7.5yrs |
| Proprietà del CEO | 0.6% |
| Durata media del management | 10.7yrs |
| Durata media del Consiglio di amministrazione | 7.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
PRA: Margins Will Improve While Revenue Pressures And Fair Value Persist
Analysts have modestly adjusted their price target for ProAssurance, maintaining it at $22.67. Updated forecasts reflect slightly higher discount rates, a softer revenue outlook, improved profit margins, and a marginally lower future price-to-earnings ratio.Future Performance Will Reflect Stable Outlook and Completed Share Repurchase Program
Analysts have slightly adjusted their price target for ProAssurance, maintaining a fair value estimate of $22.67 while taking into account a marginally lower outlook for revenue growth and profit margins. What's in the News ProAssurance reported it repurchased zero shares between April 1, 2025 and June 30, 2025, resulting in no additional spending on buybacks in this period (Key Developments).AI-Ready Web Portal Will Improve Future Customer Experience And Operational Workflows
Analysts have lowered their price target for ProAssurance from $25.00 to $22.67. This change reflects revised expectations around the company’s fair value based on recent financial performance.AI-Ready Web Portal Will Improve Future Customer Experience And Operational Workflows
Upward revisions in ProAssurance's consensus revenue growth forecasts and higher future P/E expectations have contributed to a significant increase in the fair value estimate, with the analyst price target rising from $22.67 to $25.00. What's in the News ProAssurance has completed the repurchase of 12,758,534 shares (22.5%) for $490.42 million under the buyback announced in 2011, with no shares repurchased from April 1, 2025 to June 30, 2025.ProAssurance Pops On Acquisition News, But Think Twice About Opportunity Cost
Summary ProAssurance Corporation (PRA) is being acquired by The Doctors Company, resulting in a 48% stock gain, with an 8% discount remaining on the buyout price. The acquisition, valued at $1.3 billion, is not subject to financing conditions, reducing the risk of deal failure due to funding issues. PRA's financials show modest growth and challenges, with a declining book value and underperforming return on capital employed compared to peers. Despite the high likelihood of deal closure, I recommend holding off on buying PRA now due to potential opportunity costs and waiting for a lower price. Read the full article on Seeking Alpha
AI And Predictive Analytics Initiatives Will Strengthen Future Net Margins
Strategic pricing and predictive analytics improve medical professional liability metrics, potentially enhancing revenue and margins.ProAssurance: Recent Performance Strong, But Valuation Not Compelling
Summary ProAssurance specialises in medical malpractice insurance, facing systemic negative trends and a challenging mono-line business model that suppresses ROE below capital costs. Despite recent stabilization, PRA's valuation on forward earnings is high compared to peers, and growth and momentum are slowing. ProAssurance's net income improvement is driven by increased pricing, re-underwriting initiatives, and higher interest rates, but there's no evidence of pricing above claims trends. SA Quant rates PRA stock a Strong Buy. I share how I see things. Read the full article on Seeking AlphaProAssurance Corporation's (NYSE:PRA) Price Is Out Of Tune With Revenues
It's not a stretch to say that ProAssurance Corporation's ( NYSE:PRA ) price-to-sales (or "P/S") ratio of 0.7x right...Lacklustre Performance Is Driving ProAssurance Corporation's (NYSE:PRA) Low P/S
When close to half the companies operating in the Insurance industry in the United States have price-to-sales ratios...Results: ProAssurance Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts
A week ago, ProAssurance Corporation ( NYSE:PRA ) came out with a strong set of first-quarter numbers that could...ProAssurance (NYSE:PRA) Is Due To Pay A Dividend Of $0.05
The board of ProAssurance Corporation ( NYSE:PRA ) has announced that it will pay a dividend on the 13th of April, with...ProAssurance declares $0.05 dividend
ProAssurance (NYSE:PRA) declares $0.05/share quarterly dividend, in line with previous. Forward yield 0.94% Payable Oct. 13; for shareholders of record Sept. 29; ex-div Sept. 28. See PRA Dividend Scorecard, Yield Chart, & Dividend Growth.ProAssurance Non-GAAP EPS of $1.19 beats by $1.10
ProAssurance press release (NYSE:PRA): Q2 Non-GAAP EPS of $1.19 (vs. $1.52 Y/Y) beats by $1.10. Gross premiums written were $9.58B (vs. $9.50B Y/Y).ProAssurance's (NYSE:PRA) Dividend Will Be US$0.05
ProAssurance Corporation ( NYSE:PRA ) will pay a dividend of US$0.05 on the 8th of October. This payment means the...ProAssurance (NYSE:PRA) Is Due To Pay A Dividend Of US$0.05
ProAssurance Corporation ( NYSE:PRA ) has announced that it will pay a dividend of US$0.05 per share on the 8th of...Need To Know: Analysts Are Much More Bullish On ProAssurance Corporation (NYSE:PRA) Revenues
Shareholders in ProAssurance Corporation ( NYSE:PRA ) may be thrilled to learn that the analysts have just delivered a...We Wouldn't Be Too Quick To Buy ProAssurance Corporation (NYSE:PRA) Before It Goes Ex-Dividend
It looks like ProAssurance Corporation ( NYSE:PRA ) is about to go ex-dividend in the next four days. You can purchase...Should You Buy ProAssurance Corporation (NYSE:PRA) For Its Dividend?
Is ProAssurance Corporation ( NYSE:PRA ) a good dividend stock? How can we tell? Dividend paying companies with growing...Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Utili della società |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$65m |
| Dec 31 2025 | US$5m | US$1m | US$51m |
| Sep 30 2025 | n/a | n/a | US$34m |
| Jun 30 2025 | n/a | n/a | US$49m |
| Mar 31 2025 | n/a | n/a | US$42m |
| Dec 31 2024 | US$6m | US$1m | US$53m |
| Sep 30 2024 | n/a | n/a | US$43m |
| Jun 30 2024 | n/a | n/a | -US$23m |
| Mar 31 2024 | n/a | n/a | -US$28m |
| Dec 31 2023 | US$4m | US$1m | -US$39m |
| Sep 30 2023 | n/a | n/a | -US$31m |
| Jun 30 2023 | n/a | n/a | US$9m |
| Mar 31 2023 | n/a | n/a | -US$3m |
| Dec 31 2022 | US$4m | US$987k | -US$402k |
| Sep 30 2022 | n/a | n/a | US$18m |
| Jun 30 2022 | n/a | n/a | US$39m |
| Mar 31 2022 | n/a | n/a | US$133m |
| Dec 31 2021 | US$3m | US$938k | US$144m |
| Sep 30 2021 | n/a | n/a | US$126m |
| Jun 30 2021 | n/a | n/a | -US$36m |
| Mar 31 2021 | n/a | n/a | -US$146m |
| Dec 31 2020 | US$2m | US$921k | -US$176m |
| Sep 30 2020 | n/a | n/a | -US$249m |
| Jun 30 2020 | n/a | n/a | -US$82m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$4m | US$827k | US$1m |
Compensazione vs Mercato: La retribuzione totale di Ned ($USD 5.30M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 5.26M ).
Compensazione vs guadagni: La retribuzione di Ned è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Ned Rand (59 yo)
Mr. Edward Lewis Rand, Jr., CPA., also known as Ned, is Director of Birmingham Business Alliance. Mr. Rand serves as Chief Executive Officer of ProAssurance Corporation since July 1, 2019, its President si...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 7.5yrs | US$5.30m | 0.57% $ 7.3m | |
| Executive VP | 7.8yrs | US$1.82m | 0.088% $ 1.1m | |
| Executive VP | 20.4yrs | US$1.86m | 0.19% $ 2.4m | |
| President of Medical Professional Liability | no data | US$2.15m | 0.060% $ 770.6k | |
| President of Eastern Alliance Insurance Group | 7.1yrs | US$1.59m | 0.10% $ 1.3m | |
| Chief Investment Officer | 24.4yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Chief Compliance Officer & VP | 12.4yrs | Nessun dato | Nessun dato | |
| Assistant Vice President of Public Relations | no data | Nessun dato | Nessun dato | |
| Chief Human Resources Officer & Executive VP | 11.2yrs | Nessun dato | 0.054% $ 685.2k | |
| Senior VP & Chief Claims Officer | no data | US$1.55m | Nessun dato | |
| President of Life Sciences | 10.3yrs | Nessun dato | Nessun dato |
Gestione esperta: Il team dirigenziale di PRA è esperto e expertise (durata media dell'incarico 10.7 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 7.1yrs | US$5.30m | 0.57% $ 7.3m | |
| Independent Director | 2.1yrs | US$194.77k | 0.021% $ 262.3k | |
| Independent Director | 12.4yrs | US$182.27k | 0.087% $ 1.1m | |
| Independent Director | 5.1yrs | US$174.98k | 0.049% $ 622.1k | |
| Independent Chairman | 10.1yrs | US$274.98k | 0.069% $ 880.6k | |
| Independent Director | 5.1yrs | US$187.48k | 0.049% $ 622.1k | |
| Independent Director | 2.1yrs | US$174.98k | 0.021% $ 262.3k | |
| Independent Director | 9.1yrs | US$188.73k | 0.066% $ 843.7k | |
| Independent Director | 7.1yrs | US$190.98k | 0.061% $ 773.1k |
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PRA sono considerati esperti (durata media dell'incarico 7.1 anni).
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/06/10 08:22 |
| Prezzo dell'azione a fine giornata | 2026/06/10 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
ProAssurance Corporation è coperta da 10 analisti. 3 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Robert Farnam | Brean Capital Historical (Janney Montgomery) |
| Matthew Carletti | Citizens JMP Securities, LLC |
| Meyer Shields | Keefe, Bruyette, & Woods |